What's Going On With BioVie Stock on Tuesday?
BioVie reported Phase 2 ADDRESS-LC trial results evaluating bezisterim for Long COVID, showing significant subgroup improvements.
Stocks · News reference
Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Eva Live gained 16.4% in pre-market trading after signing a letter of intent to acquire Airbeam Wireless Technologies for $16 million.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BioVie shares are trading lower. The company announced topline results from Phase 2 ADDRESS‑LC trial evaluating Bezisterim for the treatment of neurological symptoms associated with long COVID.
Trading Halt: Halt status updated at 7:55:00 AM ET: Quotation Resumption: News and Resumption Times
BioVie Announces Phase 2 ADDRESS-LC Trial Results Of Bezisterim In Long COVID
Statistically significant benefits observed in bezisterim-treated Long COVID patients in pre-specified subgroups with high baseline fatigue, cognitive impairment, and/or post‑exertional malaiseBezisterim showed a
Why Penguin Solutions Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Penguin Solutions jumped 7.7% after beating Q4 revenue/EPS estimates and issuing above-consensus FY27 EPS guidance.
Baiya International Group shares are trading higher after the company reported a year-over-year increase in its H1 EPS results.